- French MA completes decentralized procedure with MAs granted in 15 European countries
- Tibelia® is currently marketed in a number of countries through existing supply and license agreements
- Further agreements and product launches anticipated in 2017
Liège, Belgium, 29 May 2017 – Mithra (Euronext Brussels: MITRA), a company specialized in Women’s Health, announces that it has received a Marketing Authorization (MA) for the commercialization of Tibelia® in France. The French MA completes the decentralized procedure started in 2016, with MAs now granted in 15 European countries.